RHYTHM PHARMACEUTICALS, INC. (RYTM) Income Tax Expense (Benefit) USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Rhythm Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2021 to 2024.
  • Rhythm Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $300 K.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $300 K +$300 K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q3 2023 $368 K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-02
Q1 2022 $0 -$22 M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q3 2021 -$9 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$5.02 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $22 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.